baber/WOPTO huggingface dataset:
Patent DE-69405855-T2 (DE)
Inventor: CARLSSON JAN
IPC: D21C3/24
Filed: 1994-01-14
Granted: 1998-01-29
Abstract: PCT No. PCT/SE94/00020 Sec. 371 Date Aug. 14, 1995 Sec. 102(e) Date Aug. 14, 1995 PCT Filed Jan. 14, 1994 PCT Pub. No. WO94/19533 PCT Pub. Date Sep. 1, 1994The present invention relates to a straining device in association with the displacement of liquid through a pulp bed preferably in connection with the withdrawal of cooking liquid in a continuous digester (1) for producing chemical pulp, which straining device (2) is preferably rectangular and comprises a number of strainer-bars (3), arranged in parallel, which have been fixed to at least two rod elements (4, 5), which are placed transversely in relation to the lengthwise extension of the bar-strainers, the said rod elements (4, 5) being made of metal, preferably stainless steel, and having a strength value RP 0.2 at 100 DEG  C. which exceeds 200 MPA, preferably 300 MPA, and more preferably 350 MPA, and the width of the said rod element (4) being less than 800 mm, preferably 650 mm, and more preferably 550 mm, so that the straining device becomes self-supporting.
Patent DE-69406852-T2 (DE)
Inventor: KWON INN-KEUK
IPC: C08K3/34
Filed: 1994-05-26
Granted: 1998-06-18
Abstract: The composition of the present invention is a kind of crosslinked, flame -retardant resin composition, which comprises a base polymer of EVA-VC, chlorinated polyethylene, thermal stabilizers, antioxidants, flame-retardant fillers, lubricants and monomers with multifunctional group. The composition essentially comprises 100 weight parts of EVA-VC, 10 to 70 weight parts of chlorinated polyethylene, 40 to 120 weight parts of flame-retardant fillers, and 5 to 20 weight parts of monomer with multifunctional group. In addition, the composition is crosslinked by electron beam to be used as the material for sheath layer of electric wire or cable durable to high voltages.
Patent DE-69410357-T2 (DE)
Inventor: DENICOLA ANTHONY J
IPC: C08L23/10
Filed: 1994-07-15
Granted: 1998-10-08
Abstract: Disclosed is a normally solid, high molecular weight, non-linear, substantially gel-free, propylene polymer material characterized by high melt strength due to strain hardening which is believed to be caused by free-end long chain branches of the molecular chains forming the polymer. Also disclosed is a process for making the polymer by high energy radiation of a normally solid, high molecular weight, linear, propylene polymer in a reduced active oxygen environment, maintaining the irradiated material in such environment for a specific period of time, and then deactivating free radicals in the material. Further disclosed is the use of the strain hardening polymer in extensional flow operations such as, for example, extrusion coating, film production, foaming and thermoforming. <IMAGE>
Patent DE-69412476-T2 (DE)
Inventor: HESSE ROBERT
IPC: C07D295/185
Filed: 1994-05-06
Granted: 1999-03-11
Abstract: PCT No. PCT/GB94/00975 Sec. 371 Date Jan. 5, 1996 Sec. 102(e) Date Jan. 5, 1996 PCT Filed May 6, 1994 PCT Pub. No. WO94/26707 PCT Pub. Date Nov. 24, 1994The invention relates to novel 1 alpha -hydroxy vitamin D derivatives and their 20-epi analogues, comprising compounds of general formula (I)    <IMAGE>  (I)  where R1 and R2, which may be the same or different, each represents a hydrogen atom or an aliphatic, cycloaliphatic, araliphatic or aryl group or together with the nitrogen atom to which they are attached form a heterocyclic group; R3 represents a methyl group having  alpha - or  beta -configuration; X represents a valence bond or a C1-2alkylene group; Y represents -O-, -S-, -CH2- or -NR- where R is a hydrogen atom or an organic group; Z represents a valence bond or a C1-3alkylene group; and A= represents a cyclohexylidene moiety characteristic of the A-ring of a 1 alpha -hydroxylated vitamin D or analogue thereof, with the proviso that when -X-Y-Z- together represent an alkylene group containing up to 4 carbon atoms A= does not carry an exocyclic methylene group at the 10-position. Active compounds of the invention exhibit cell modulating activity while exhibiting a substantial lack of calcemic effect.\!
Patent DE-69423500-T2 (DE)
Inventor: ENDRESS DIPL-ING
IPC: H04N5/44
Filed: 1994-12-12
Granted: 2000-09-14
Abstract: A method and an apparatus for simultaneously displaying two independent video signals are described. The apparatus comprises vedlo signal input terminals (2, 6) for receiving first and second video signals in PAL system having the field frequency of 50 Hz, Y/C processors (7, 8) connected to the video signal input terminals (2, 6), A/D converters (16, 24) connected to the Y/C processors two port field memories (17, 22) having a random block addressing mode for storing the digital Y/U/V signals from the A/D converters, a D/A converter (19) connected to an output of the field memories (17, 22) and deriving analog Y/U/V signals which are converted to R/G/B signals and supplied to a display (10), a write and read control signal generator (14; 20, 21) for generating first and second write control signals so that the first and second digital Y/U/V signals are written into the first and second field memories (17, 22) at a first predetermined frequency in sychronism with the synchronizing signals of the first and second video signals, respectively, and for generating frist and second read control signals so that the first and second digital Y/U/V signals are alternately linewise read-out from the first and second field memories (17, 22) at four times the first predetermined frequency in sychronism with a master sychronizing signal of either the first or second video signals and which are displayed each in an aspect ratio of 4:3 or 3:3 on the screen having a wide aspect ratio of 16:9 in a 100 Hz flickerless mode. <IMAGE>
Patent DE-69425444-T2 (DE)
Inventor: GOULD JOHN
IPC: C08J5/02
Filed: 1994-12-02
Granted: 2001-02-08
Abstract: An article having a decorative visual surface appearance provided by a plastics composition which comprises a transparent or translucent plastics material having a colorant dispersed therein is characterised in that the colorant comprises a blend of discrete polymer particles substantially all of which have a minimum dimension in the range of 5 to 100 micron and a maximum dimension of no more than 10 mm, said particles being of a natural or synthetic organic polymer or a glass, the blend comprising particles of at least two distinct colors and/or shapes, and the plastics composition containing 0.1 to 8 percent by weight of the blend of polymer particles based on the weight of the plastics composition. The article can be made by a method which includes the steps of mixing together the blend and the plastics material or a precursor thereof and forming the article under conditions whereby the polymer particles in the colorant are not deformed to any substantial extent. The colored particles may be provided in a color concentrate homogeneously mixed with a polymer or precursor thereof or a wax. The articles may be moulded, cast, extruded, calendered or reinforced plastics articles, for example floor coverings.
Patent DE-69428371-T2 (DE)
Inventor: VERRIER RICHARD L
IPC: A61B5/361
Filed: 1994-11-30
Granted: 2002-07-04
Abstract: A method and apparatus for predicting susceptibility to sudden cardiac death simultaneously assessing cardiac electrical stability and autonomic influence. Cardiac electrical stability is assessed by analyzing at least one of a beat-to-beat alternation in a T-wave of an ECG of a patient's heart and dispersion of repolarization in the ECG of the patient's heart. Autonomic influence on the patient's heart is assessed by analyzing at least one of a magnitude of heart rate variability in the ECG of the patient's heart and baroreceptor sensitivity.
Patent DE-69430898-T2 (DE)
Inventor: ATKINSON PAUL ROBERT
IPC: C12P21/06
Filed: 1994-12-14
Granted: 2003-01-23
Abstract: The present invention concerns a novel process for using a recently discovered dipeptidylaminopeptidase isolated from the cellular slime mold, Dictyostelium discoideum (dDAP). The claimed process involves immobilizing dDAP onto a support surface so that even numbered, N-terminal dipeptides can be efficiently removed from precursor proteins or polypeptides to yield desired processed proteins or polypeptides. The invention provides a means for reusing dDAP in multiple conversion reaction runs, as the enzyme does not become a part of the substrate/product solution. The claimed process is particularly useful for converting a precursor human proinsulin analog (Met-Arg-Human Proinsulin having Lys at position 28 and Pro at position 29 of the corresponding insulin B-chain; MR-KPB-hPI) to a processed insulin analog (Human Proinsulin having Lys at position 28 and Pro at position 29 of the corresponding insulin B-chain, KPB-hPI).
Patent DE-69434564-T2 (DE)
Inventor: MALLET JACQUES
IPC: C12N15/86
Filed: 1994-09-29
Granted: 2006-08-10
Abstract: Use of a cpd. (A) that at least partly inhibits the activity of p53 protein to prepare a compsn. for treating and/or preventing neurodegenerative diseases is new. Also claimed is recombinant virus contg., inserted in its genome, nucleic acid (a) encoding a mutated form of p53 able to antagonise p53 activity; (b) contg. all or part of the p53 binding site and/or (c) encoding antisense material able to reduce p53 expression at translational or transcriptional levels.
Patent DE-69511158-T2 (DE)
Inventor: GARDNER NICHOLAS ALAN
IPC: F16K27/00
Filed: 1995-05-12
Granted: 1999-11-25
Abstract: A refrigerator unit provided with a control means comprising a plurality of valve means (26,80.81,82,100,102,104), the control means comprising a unitary valve manifold (16) made as a one piece casting having said valve means (26,80,81,82,100,102,104) operatively mounted thereon.
Patent DE-69512416-T2 (DE)
Inventor: LAUB RUTH
IPC: A61K35/14
Filed: 1995-07-14
Granted: 2000-02-17
Abstract: PCT No. PCT/BE95/00069 Sec. 371 Date Jul. 7, 1997 Sec. 102(e) Date Jul. 7, 1997 PCT Filed Jul. 14, 1995 PCT Pub. No. WO96/02571 PCT Pub. Date Feb. 1, 1996A fibrinogen concentrate has a purity of 98% or higher and is free of viral contaminants and proteases. The fibrinogen concentrate is obtained by subjecting a solubilized plasma fraction containing fibrinogen to a viral inactivation chemical treatment using a solvent/detergent, subjecting the resulting viral-inactivated fraction to precipitation in a solution containing an amino acid at an acidic pH to obtain a supernatant, filtering the supernatant to obtain a purified fibrinogen concentrate, and recovering the purified fibrinogen concentrate.
Patent DE-69515800-T2 (DE)
Inventor: HOLLEBOOM RENE GASTON
IPC: F16L3/10
Filed: 1995-11-07
Granted: 2000-07-06
Abstract: A fixing bracket (10) for pipes comprises an essentially strip-shaped bracket body (32, 34) consisting of one or more parts, on which a strip-shaped covering (36, 38) made of elastomeric material is fitted at least on the inside of the bracket body facing the pipe accommodated in the bracket during use of the bracket. The longitudinal side edges (40, 42) of the strip-shaped bracket body (32, 34) are bent over towards the inside of the bracket body, and the bent-over side edges are bent towards each other in the transverse direction of the bracket body. The strip-shaped covering (36, 38) is clamped in the transverse direction between the longitudinal side edges of the bracket body which have been bent towards each other. <IMAGE>
Patent DE-69516519-T2 (DE)
Inventor: TOMIOKA HISAO
IPC: A61K31/519
Filed: 1995-02-24
Granted: 2000-10-12
Abstract: 9-methyl-3-(1H-tetrazol-5yl) -4H-pyrido Ä1, 2-aÜ pyrimidin-4-one represented by the following formula; <CHEM> and the physiologically-acceptable salts thereof showed to have excellent inhibitory effect on the proliferation of vascular smooth muscle cells and are effective to prevent the occurrence of restenosis after the operation of PTCA, and hence the compounds can be useful for the therapeutic and preventive treatment for arteriosclerosis and other diseases whereto the proliferation of vascular smooth muscle cells is directly concerned.
Patent DE-69519011-T2 (DE)
Inventor: CHAUVIN BERNARD
IPC: A21D13/00
Filed: 1995-04-20
Granted: 2001-05-10
Abstract: Method for the manufacture of a food product enclosed in a pastry case and products so obtained. The invention involves a method for the manufacture of a food product (P) with an edible pastry case (E) filled with a garnishing or the like, the food produit completely filling the case. The method is characterized in that the pastry case (E) and the garnishing, filling or the like are cooked simultaneiously in a humid atmosphere present at least around the product.
Patent DE-69520083-T2 (DE)
Inventor: CAGLIOSTRO CHARLES W
IPC: G07B15/06
Filed: 1995-09-01
Granted: 2001-09-06
Abstract: A hand held, unitary assembly, data collection device (10) for an off-line vending machine such as a parking meter (60), which is operable by smart integrated circuit chip cards. The vending machine (60) has a chip card reader, and which stores data as to the sale of goods/services from the machine. The device (10) has a first portion (12) which mechanically and electrically fits the vending machine reader; and a second portion (20) with an opening to receive a PCMCIA card (30). Data is retrieved and transferred to the PCMCIA card. The first and second portions (12,20) are rigidly joined to one another forming a unitary assembly, and the second portion (20) securely holds the PCMCIA card (30), and is also a handle for qripping the device (10). <MATH>
Patent DE-69521620-T2 (DE)
Inventor: HELLBERG R
IPC: A61K31/557
Filed: 1995-09-25
Granted: 2001-10-18
Abstract: Disclosed are 9-deoxyprostaglandins which are useful in the treatment of glaucoma and ocular hypertension. Some of these 9-deoxyprostaglandins are novel. Also disclosed are ophthalmic, pharmaceutical compositions comprising such prostaglandins.
Patent DE-69527725-T2 (DE)
Inventor: FELT C
IPC: A61F2/28
Filed: 1995-05-04
Granted: 2003-04-30
Abstract: A system for resurfacing orthopedic joints by arthroscopic means. The system involves a method that includes the delivery of a curable biomaterial, and the use of minimally invasive means to prepare an injury site, and then deliver, cure and shape a curable biomaterial at the site of injury.
Patent DE-69530220-T2 (DE)
Inventor: TOTTEN J
IPC: B67D1/07
Filed: 1995-11-13
Granted: 2004-02-12
Abstract: A self-sealing bag valve for use with a quick-disconnect coupling in a bag-in-box (BIB) syrup dispensing assembly for a post-mix beverage dispenser includes a plastic spring assembly for normally biasing a poppet of a self-sealing valve into sealing engagement with a valve seat thereof. The spring assembly includes a petaloid-shaped disc having evenly spaced petaloid segments defining flow passages therebetween, a retaining ring for securing peripheral portions of the petaloid-shaped disc in fixed positions in the bore of the self-sealing valve and a petaloid stem protruding from the disc into engagement with the valve poppet. The petaloid-shaped disc includes a first frusto-conical portion extending from the retaining ring to a circular termination line concentric with the ring and a second frusto-conical portion extending from the circular termination line to the petaloid stem. The first and second frusto-conical portions, when in an installed, normal biasing position (the closed position of the self-sealing valve), have opposite slopes with respect to an axis orthogonal to the petaloid disc providing a bend about the circular termination lines forming knees in each petaloid segment for accommodating flexing of the elements about the knees. A groove is provided in the central bore of the valve housing for accommodating a snap-fit of the retaining ring therein.
Patent DE-69609936-T2 (DE)
Inventor: ISHIKAWA YOSHITAKA
IPC: F23G5/00
Filed: 1996-12-11
Granted: 2001-01-04
Abstract: In a method of recycling iron and steel industry waste (1-1, 1-2) by processing the waste (1-1, 1-2) as an object substance by the use of a rotary kiln (7), the object substance is changed into a valuable material while the object substance travels within the rotary kiln (7) from an upstream side to a downstream side. The object substance is heated on the upstream side of the rotary kiln (7) within a reducing atmosphere to be reduced and molten into a reduced and molten product. The reduced and molten product is quickly sent to the downstream side without being adhered to an internal wall of the rotary kiln (7). The valuable material is extracted from the reduced and molten product which may be directly discharged out of the rotary kiln or which may be discharged after the reduced and molten product is once kept in a basin formed in the vicinity of the downstream side of the rotary kiln (7). <IMAGE>
Patent DE-69610309-T2 (DE)
Inventor: PATERSON G
IPC: A61B18/12
Filed: 1996-06-03
Granted: 2001-02-22
Abstract: A power control apparatus for an electrosurgical generator is used for controlling output power from the generator to the tissue or bodily fluids of a patient. The control apparatus rapidly determines the range of impedance of the load on the electrosurgical generator and adjusts the output power accordingly. Output current and output voltage from the electrosurgical generator are monitored and sent to a microprocessor. The microprocessor runs an algorithm that determines the impedance range of the load on the generator. The algorithm uses computational techniques, such as comparisons and bit shifting, that avoid long division and other time-consuming operations. The microprocessor can then adjust a high voltage power supply that effects the radio frequency amplifier stage. A method for controlling the power of the electrosurgical generator, including steps in the algorithm, is also disclosed.
Patent DE-69616016-T2 (DE)
Inventor: DURET PIERRE
IPC: F02B61/04
Filed: 1996-07-25
Granted: 2002-03-14
Abstract: PCT No. PCT/FR96/01173 Sec. 371 Date Aug. 15, 1997 Sec. 102(e) Date Aug. 15, 1997 PCT Filed Jul. 25, 1996 PCT Pub. No. WO97/09518 PCT Pub. Date Mar. 13, 1997The present invention relates to a process for delivering and for metering additives to the combustion chamber of an internal-combustion engine consuming a known and controlled amount of lubricant, according to which the lubricant consumed comprises at least one additive designed to improve the quality of the combustion in the chamber. In particular, the additive is designed to promote the combustion of an engine working with controlled self-ignition and to obtain operation in a wider speed and/or load range of the engine.
Patent DE-69617481-T2 (DE)
Inventor: HALTTUNEN MIKKO
IPC: B60R11/00
Filed: 1996-01-19
Granted: 2002-08-01
Abstract: A telephone holder according to the present invention includes a carrier (101) and a body (102), which are able to move vertically in relation to each other between two extreme positions. In the first extreme position an electrical connector of the telephone (111) is galvanically connected to a counterpart (109) of the connector in the holder. In the second extreme position the connector is disconnected from the counterpart. The carrier is joined to the body by means of slide surfaces (103, 104), which permit the carrier to move back and forth vertically in relation to the body between said extreme positions. The movement and its extent are governed by springs (106), for example. The holder according to the present invention can be accurately formed according to the contours of the telephone (111), preventing the telephone from moving laterally while in the holder, facilitating alignment of the connector with the counterpart (109). <IMAGE>
Patent DE-69617659-T2 (DE)
Inventor: MURRER ANTHONY
IPC: C01F17/00
Filed: 1996-03-19
Granted: 2002-10-02
Abstract: PCT No. PCT/GB96/00575 Sec. 371 Date Jan. 2, 1998 Sec. 102(e) Date Jan. 2, 1998 PCT Filed Mar. 19, 1996 PCT Pub. No. WO96/30029 PCT Pub. Date Oct. 3, 1996Selected lanthanum carbonate hydrates may be administered into the gastrointestinal tract, to treat hyperphosphataemia in patients with renal failure.
Patent DE-69624249-T2 (DE)
Inventor: FORBUS S
IPC: C09C1/42
Filed: 1996-03-21
Granted: 2003-06-26
Abstract: A selected kaolin crude or crude fraction is purified by physical or physical/chemical means, such as froth flotation and/or selective flocculation, to remove discrete particles of TiO2 and in some cases, discrete iron minerals. The pure (or purified clay) must then be agitated in the presence of water with a particulate grinding media such as, for example, sand, alumina or zirconia beads, to increase the 2 micron content of the kaolin. An intermediate ground product that contains a substantial weight percentage of particles finer than 1 micron is generated as a result of grinding. The particles finer than 1 micron in the ground kaolin also include those particles in the previously pure or purified kaolin that were present in the naturally occurring clay. A pulp of the ground clay is then fractionated to remove particles larger than 2 microns, e.g., to remove at least 95%, preferably at 100% by weight, of the particles larger than 2 microns, while minimizing the removal of particles finer than 1 micron. The resulting fine particles size fraction is then treated by conventional series of steps, i.e., optional bleaching, drying, pulverization, calcination and repulverization to produce a low abrasion, ultrahigh brightness (typically 96%) calcined kaolin pigment.
Patent DE-69631058-T2 (DE)
Inventor: AXELSSON OSKAR
IPC: C07D491/10
Filed: 1996-09-13
Granted: 2004-06-03
Abstract: PCT No. PCT/EP96/04039 Sec. 371 Date May 29, 1998 Sec. 102(e) Date May 29, 1998 PCT Filed Sep. 13, 1996 PCT Pub. No. WO97/10212 PCT Pub. Date Mar. 20, 1997The present invention discloses compounds of the formula any of its enantiomers or any mixture thereof, or a pharmaceutically-acceptable addition salt thereof, wherein X, Ar, R, R1, R2, n are as defined herein.
Patent DE-69631127-T2 (DE)
Inventor: KADOMA H
IPC: C12N9/10
Filed: 1996-05-16
Granted: 2004-07-08
Abstract: The invention includes novel fusion DNA sequences encoding fusion polypeptides which when expressed in Aspergillus result in the expression of fusion polypeptides which when secreted result in increased levels of secretion of the desired polypeptide as compared to the expression and secretion of such polypeptides from other host systems.
Patent DE-69632014-T2 (DE)
Inventor: MOLLIERE ETIENNE
IPC: B66B5/00
Filed: 1996-11-27
Granted: 2004-08-12
Abstract: The invention relates to a procedure and an apparatus for analyzing elevator functions and detecting deviating functions. By monitoring signals associated with traffic events in the elevator system, an analyzer connected to the elevator learns the normal operation of the elevator independently. Signals occurring during operation are compared with the information thus acquired and a failure alarm is produced or said information is altered to make it accord with the new, changed situation.
Patent DE-69635654-T2 (DE)
Inventor: FEINGOLD VLADIMIR
IPC: A61F2/16
Filed: 1996-01-04
Granted: 2006-06-29
Abstract: An intraocular lens injection system and method of injecting an intraocular lens. The intraocular lens injection system includes an injecting device with a converging passageway (416), and grooves (410) for curling the ends of the deformable intraocular lens (64) into a folded position prior to insertion into the eye.
Patent DE-69702060-T2 (DE)
Inventor: POULSEN BLOCK
IPC: B29C63/06
Filed: 1997-06-18
Granted: 2001-01-18
Abstract: The present invention relates to a process for continuous preparation of pipe sections with foil for insulation purposes, wherein an elongated, cylindrical shaped member (4) being slitted in the longitudinal direction is advanced axially, and where a plane foil (1) is shaped to tubular shape which surrounds the shaped member from slit edge to slit edge, and where the foil is made to adhere to the surface of the shaped member. The foil (1) is shaped using shaping tools (6), and without essentially using the shaped member (4) as support in the shaping process.